Advertisement
Advertisement

ATRC

ATRC logo

AtriCure, Inc.

28.66
USD
Sponsored
+0.35
+1.24%
Apr 02, 14:28 UTC -4
Open

ATRC Earnings Reports

Positive Surprise Ratio

ATRC beat 31 of 41 last estimates.

76%

Next Report

Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$142.35M
/
-$0.07
Implied change from Q4 25 (Revenue/ EPS)
+1.32%
/
-275.00%
Implied change from Q1 25 (Revenue/ EPS)
+15.15%
/
-50.00%

AtriCure, Inc. earnings per share and revenue

On Feb 17, 2026, ATRC reported earnings of 0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.09 USD, resulting in a 141.28% surprise. Revenue reached 140.50 million, compared to an expected 142.57 million, with a -1.45% difference. The market reacted with a -3.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 142.35 million USD, implying an decrease of -275.00% EPS, and increase of 1.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.07
Actual
-$0.66
Surprise
-1005.35%
logo
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$3.14
Surprise
+640.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
logo
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.01
Surprise
-149.02%
logo
IM Cannabis Corp. Common Shares
Report Date
Mar 30, 2026 For Q4 25
Estimate
$0.12
Actual
-$1.19
Surprise
-1055.53%
FAQ
For Q4 2025, AtriCure, Inc. reported EPS of $0.04, beating estimates by 141.28%, and revenue of $140.50M, -1.45% below expectations.
The stock price moved down -3.29%, changed from $37.64 before the earnings release to $36.40 the day after.
The next earning report is scheduled for Apr 27, 2026.
Based on 11 analysts, AtriCure, Inc. is expected to report EPS of -$0.07 and revenue of $142.35M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement